0.30Open0.30Pre Close151 Volume1.29K Open Interest13.00Strike Price3.52KTurnover3692.86%IV7.23%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1405Delta0.3114Gamma243.40Leverage Ratio-85.6894Theta0.0000Rho34.19Eff Leverage0.0000Vega
CorMedix Stock Discussion
Until it wasn’t… Joe Todisco’s leadership, as CEO, troubles me.
CORMEDIX INC. ANNOUNCES PRELIMINARY FOURTH QUARTER 2024 RESULTS AND PROVIDES BUSINESS UPDATE - CorMedix | Prevention of cardiac, renal and infectious diseases
$72-78mm spending in 2025, “…largely driven by R&D,” they said?
“[Co...
Time to call it a day
No comment yet